Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geetha Narayanan

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Cancer Research and Therapeutics|July 28, 2022
Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21 - A comprehensive cytogenetic profiling of three cases with review of literatureT V Akhila Raj, Preethi Gopinath, J A Geetha Raj, et al.
BMC Cancer|December 21, 2025
Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer centerSenthamizhan Sundaramoorthy, George Abraham, Geetha Narayanan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2026
Cytogenetic Profile of Newly Diagnosed Acute Myeloid Leukemia Patients: Insights from a Study at a Tertiary Care Centre in South IndiaDevipriya Padmakumar, Vineetha Radhakrishnan Chandraprabha, Jagathnath Krishna Kumarapillai Mohanan Nair, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 29, 2024
Exploring the Prevalence and Prognostic Impact of Wilms Tumor 1 Exon 7 Mutation Status with Combinations of FLT3-ITD and NPM1 Mutations as Potential Molecular Biomarkers in Acute Myeloid Leukemia Patients with Normal CytogeneticsGeetha Raj John Anitha, Vineetha Radhakrishnan Chandraprabha, Devipriya Padmakumar, et al.
The Lancet. Oncology|June 2, 2012
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trialRuth Pettengell, Bertrand Coiffier, Geetha Narayanan, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Cancer Research and Therapeutics|July 28, 2022
Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21 - A comprehensive cytogenetic profiling of three cases with review of literatureT V Akhila Raj, Preethi Gopinath, J A Geetha Raj, et al.
BMC Cancer|December 21, 2025
Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer centerSenthamizhan Sundaramoorthy, George Abraham, Geetha Narayanan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2026
Cytogenetic Profile of Newly Diagnosed Acute Myeloid Leukemia Patients: Insights from a Study at a Tertiary Care Centre in South IndiaDevipriya Padmakumar, Vineetha Radhakrishnan Chandraprabha, Jagathnath Krishna Kumarapillai Mohanan Nair, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 29, 2024
Exploring the Prevalence and Prognostic Impact of Wilms Tumor 1 Exon 7 Mutation Status with Combinations of FLT3-ITD and NPM1 Mutations as Potential Molecular Biomarkers in Acute Myeloid Leukemia Patients with Normal CytogeneticsGeetha Raj John Anitha, Vineetha Radhakrishnan Chandraprabha, Devipriya Padmakumar, et al.
The Lancet. Oncology|June 2, 2012
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trialRuth Pettengell, Bertrand Coiffier, Geetha Narayanan, et al.
Pageof 5